Alerts will be sent to your verified email
Verify EmailCHANDAN
|
Chandan Healthcare
|
Aspira Pathlab&Diagn
|
Nephro Care India
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
17.49 % | 5.54 % | 144.26 % |
|
5yr average Equity Multiplier
|
2.9 | 1.42 | 18.06 |
|
5yr Average Asset Turnover Ratio
|
1.36 | 1.0 | 1.28 |
|
5yr Avg Net Profit Margin
|
4.66 % | -3.89 % | 8.51 % |
|
Price to Book
|
3.62 | 11.9 | 1.95 |
|
P/E
|
22.86 | 2551.48 | 33.06 |
|
5yr Avg Cash Conversion Cycle
|
9.38 Days | -26.26 Days | -60.13 Days |
|
Inventory Days
|
27.59 Days | 10.15 Days | 6.87 Days |
|
Days Receivable
|
59.72 Days | 38.11 Days | 13.4 Days |
|
Days Payable
|
159.41 Days | 81.06 Days | 75.6 Days |
|
5yr Average Interest Coverage Ratio
|
5.07 | 0.45 | 32.99 |
|
5yr Avg ROCE
|
20.92 % | -0.04 % | 25.8 % |
|
5yr Avg Operating Profit Margin
|
10.41 % | 6.02 % | 13.74 % |
|
5 yr average Debt to Equity
|
0.68 | 0.1 | 10.46 |
|
5yr CAGR Net Profit
|
n/a | n/a | 109.59 % |
|
5yr Average Return on Assets
|
5.96 % | -2.37 % | 12.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.55 % | 18.39 % | 61.71 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.12 % | -1.08 % | 0.33 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Chandan Healthcare
|
Aspira Pathlab&Diagn
|
Nephro Care India
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|